Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-27T22:52:01.206Z Has data issue: false hasContentIssue false

Immunity in trypanosomiasis

III. Sensitivity of antibody-resistant strains to chemotherapeutic drugs

Published online by Cambridge University Press:  06 April 2009

M. A. Soltys
Affiliation:
Department of Animal Pathology, University of Cambridge

Extract

Antibody-resistant strains are less sensitive to suramin and antrycide than antibody-sensitive strains. When living trypanosomes were exposed to suramin and antrycide in vitro, antibody-resistant strains needed 50 times more drugs than antibody-sensitive trypanosomes in order to make them non-infectious to mice. In therapeutic experiments in mice the minimal therapeutic dose of drugs for antibody-sensitive strains was 0·1 mg. but for resistant strains it was 0·3 mg./20 g. mice. Rabbits treated prophylactically with suramin resisted infection with the antibody-sensitive strain for a period of 4 months, but failed to resist infection with the antibody-resistant strain after 2 months.

Rabbits treated prophylactically with antrycide pro-salt, resisted infection with antibody-sensitive strains for a period of 2 months, but failed to resist infection with the antibody-resistant strain even 1 month after injection with the drug. Although trypanosomes can become drug resistant without being antibody resistant it is suggested that, under natural conditions, drug-resistant strains in animals and man develop from antibody-resistant strains, particularly when trypanostatic drugs are used. It is suggested in conclusion from these experiments that strains of trypanosomes which are exposed for some time to antibodies and become antibody resistant after passage through animals like rabbits, as well as those strains frequently passaged through mice, should be used in all tests for the efficiency of chemotherapeutic drugs.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1959

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Browning, C. H. (1927). Biological principles in immunity. Brit. Med. J. 2, 978.Google Scholar
Dunne, H. W., Luedke, A. I., Reich, C. V. & Hokanson, J. F. (1957). The in vitro growth of hog cholera virus in cells of peripheral blood. Amer. J. Vet. Res. 28, 502.Google Scholar
Ehklich, P. & Gondbb, R. (1920). Experimentelle chemotherapie. Prowazeks Handb. Patholog. Protozoen, 2, 752.Google Scholar
Hawking., F. (1939). Contribution on the mode of action of Germanin (Bayer 205). Ann. Trop. Med. Parasit. 33, 13.CrossRefGoogle Scholar
Jancsó, N. & Jancsó, H. (1934). The role of the natural defence forces in the evolution of the drug resistance of trypanosomes. I. A method for the exclusion of the natural defence mechanisms from chemotherapeutic processes. Ann. Trop. Med. Parasit. 28, 419.CrossRefGoogle Scholar
Jancsó, N. & Jancsó, H. (1935). The role of the natural defence forces in the evolution of the drug resistance of trypanosomes. II. The rapid production of germanin-fast T. brucei strains in animals with paralysed defence. Ann. Trop. Med. Parasit. 29, 95.Google Scholar
Mesnil, F. & Brimont, E. (1908). Sur les propriétés des races de trypanosomes résistantes aux médicaments. Ann. Inst. Pasteur, 22, 856.Google Scholar
Moore, B., Niebenstein, M. & Todd, J. L. (1908). Notes on the effects of therapeutic agents on trypanosomes in respect of (a) acquired resistance of the parasites to the drug and (6) changes in virulence of the strains after escape from the drug. Ann. Trop. Med. Parasit. 2, 221.Google Scholar
Polge, C. & Soltys, M. A. (1957). Preservations of trypanosomes in the frozen state. Trans. R. Soc. Trop. Med. Hyg. 51, 519.Google Scholar
Soltys, M. A. (1957 a). Immunity in trypanosomiasis. I. Neutralization reaction. Parasitology, 47, 375.Google Scholar
Soltys, M. A. (1957 b). Immunity in trypanosomiasis. II. Agglutination reaction with African trypanosomes. Parasitology, 47, 390.CrossRefGoogle ScholarPubMed
Yorke, W. & Hawking, F. (1932). Studies in chemotherapy. VII. Is the resistance of a drug-fast trypanosome modified by transference to a different species of vertebrate host? Ann. Trop. Med. Parasit. 26, 215.CrossRefGoogle Scholar
Yorke, W., Mubgatboyd, F. & Hawking, F. (1932). Studies in chemotherapy. VIII. Comparison of strains of T. rhodesiense made resistant to various arsenicals and antimonials to Bayer 205 and to acrifiavine respectively. Ann. Trop. Med. Parasit. 26, 577.Google Scholar